These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 12903811

  • 1. p53 gene mutations in non-small cell lung cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis.
    Zhao Y, Wu D, Xiang X, Zhang B, Zhou N, Hu Y.
    Chin Med Sci J; 1999 Sep; 14(3):134-7. PubMed ID: 12903811
    [Abstract] [Full Text] [Related]

  • 2. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.
    Oncogene; 1998 May 14; 16(19):2469-77. PubMed ID: 9627113
    [Abstract] [Full Text] [Related]

  • 3. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
    Ludovini V, Pistola L, Gregorc V, Floriani I, Rulli E, Piattoni S, Di Carlo L, Semeraro A, Darwish S, Tofanetti FR, Stocchi L, Mihaylova Z, Bellezza G, Del Sordo R, Daddi G, Crinò L, Tonato M.
    J Thorac Oncol; 2008 Apr 14; 3(4):365-73. PubMed ID: 18379354
    [Abstract] [Full Text] [Related]

  • 4. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K, Ishida H, Furukawa T, Koyanagi K, Miyamoto Y.
    Rinsho Byori; 1996 Jan 14; 44(1):32-41. PubMed ID: 8691638
    [Abstract] [Full Text] [Related]

  • 5. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.
    Huang CL, Taki T, Adachi M, Konishi T, Higashiyama M, Kinoshita M, Hadama T, Miyake M.
    Int J Oncol; 1998 Mar 14; 12(3):553-63. PubMed ID: 9472092
    [Abstract] [Full Text] [Related]

  • 6. Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes.
    Fujita T, Kiyama M, Tomizawa Y, Kohno T, Yokota J.
    Int J Oncol; 1999 Nov 14; 15(5):927-34. PubMed ID: 10536175
    [Abstract] [Full Text] [Related]

  • 7. [Detection of the p53 protein accumulation and p53 gene mutation in squamous cell carcinoma of the lung].
    Li S, Liu H, Wang D.
    Zhonghua Bing Li Xue Za Zhi; 1998 Apr 14; 27(2):123-6. PubMed ID: 11244963
    [Abstract] [Full Text] [Related]

  • 8. Coalterations of p53 and PTEN tumor suppressor genes in non-small cell lung carcinoma patients.
    Andjelkovic T, Bankovic J, Stojsic J, Milinkovic V, Podolski-Renic A, Ruzdijic S, Tanic N.
    Transl Res; 2011 Jan 14; 157(1):19-28. PubMed ID: 21146147
    [Abstract] [Full Text] [Related]

  • 9. Association between p53 mutation and clinicopathological features of non-small cell lung cancer.
    Guang SG, Ogura T, Sekine I, Yokozaki M, Esumi H, Kodama T, Nagai K.
    Jpn J Clin Oncol; 1997 Aug 14; 27(4):211-5. PubMed ID: 9379505
    [Abstract] [Full Text] [Related]

  • 10. Exon 8 mutation of p53 gene associated with nodal metastasis in non-small-cell lung cancer.
    Lee LN, Shew JY, Sheu JC, Lee YC, Lee WC, Fang MT, Chang HF, Yu CJ, Yang PC, Luh KT.
    Am J Respir Crit Care Med; 1994 Dec 14; 150(6 Pt 1):1667-71. PubMed ID: 7952630
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of mutation types of p53 gene and possible carcinogenic factors in lung cancer].
    Gao ZQ, Gao Z, Zhang X.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Mar 14; 31(2):88-91. PubMed ID: 9812619
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of mutations and a germ line polymorphism of the p53 gene in non-small cell lung carcinoma: association with clinicopathological features.
    Tagawa M, Murata M, Kimura H.
    Cancer Lett; 1998 Jun 05; 128(1):93-9. PubMed ID: 9652798
    [Abstract] [Full Text] [Related]

  • 13. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H, Ogura T, Yokose T, Nagai K, Nishiwaki Y, Esumi H.
    Hum Pathol; 2001 Oct 05; 32(10):1043-9. PubMed ID: 11679937
    [Abstract] [Full Text] [Related]

  • 14. A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients.
    Kondo K, Tsuzuki H, Sasa M, Sumitomo M, Uyama T, Monden Y.
    J Surg Oncol; 1996 Jan 05; 61(1):20-6. PubMed ID: 8544455
    [Abstract] [Full Text] [Related]

  • 15. The HAUSP gene plays an important role in non-small cell lung carcinogenesis through p53-dependent pathways.
    Masuya D, Huang C, Liu D, Nakashima T, Yokomise H, Ueno M, Nakashima N, Sumitomo S.
    J Pathol; 2006 Apr 05; 208(5):724-32. PubMed ID: 16450335
    [Abstract] [Full Text] [Related]

  • 16. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
    Chang MY, Chong IW, Chen FM, Wang JY, Cheng TL, Cheng YJ, Sheu CC, Hung SY, Yang MC, Lin SR.
    Cancer Lett; 2005 May 26; 222(2):195-204. PubMed ID: 15863268
    [Abstract] [Full Text] [Related]

  • 17. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H.
    Cancer Res; 1998 Jan 15; 58(2):328-33. PubMed ID: 9443413
    [Abstract] [Full Text] [Related]

  • 18. [Diagnosis of lymph node micrometastases in human lung carcinoma: determination of p53 gene mutations by polymerase chain reaction-temperature gradient gel electrophoresis (PCR-TGGE)].
    Xu ML, Wu BQ, Zhong HH, Yang X, Heng WJ.
    Ai Zheng; 2004 Jul 15; 23(7):794-8. PubMed ID: 15248914
    [Abstract] [Full Text] [Related]

  • 19. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
    Liu D, Huang CL, Kameyama K, Hayashi E, Yamauchi A, Sumitomo S, Yokomise H.
    Cancer; 2002 Apr 15; 94(8):2239-47. PubMed ID: 12001123
    [Abstract] [Full Text] [Related]

  • 20. [p53 gene abnormalities in advanced primary lung cancer and metastatic tumors].
    Taniguchi Y.
    Nihon Ika Daigaku Zasshi; 1995 Jun 15; 62(3):241-50. PubMed ID: 7615696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.